These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7878644

  • 1. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
    Hargreaves PG, Licking EF, Sargeant P, Sage SO, Barnes MJ, Farndale RW.
    Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
    Martinson EA, Scheible S, Presek P.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
    [Abstract] [Full Text] [Related]

  • 3. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses.
    Nakashima S, Koike T, Nozawa Y.
    Mol Pharmacol; 1991 Apr; 39(4):475-80. PubMed ID: 2017148
    [Abstract] [Full Text] [Related]

  • 4. [Effect of tyrosine kinase and tyrosine phosphatase inhibitors on ATP- and thapsigargin-induced CA2+ entry in rat peritoneal macrophages].
    Krutetskaia ZI, Levedev OE, Tiushev VE, Krutetskaia NI, Roshchina NG.
    Tsitologiia; 1997 Apr; 39(2-3):164-76. PubMed ID: 9312907
    [Abstract] [Full Text] [Related]

  • 5. The tyrosine kinase inhibitors methyl 2,5-dihydroxycinnamate and genistein reduce thrombin-evoked tyrosine phosphorylation and Ca2+ entry in human platelets.
    Sargeant P, Farndale RW, Sage SO.
    FEBS Lett; 1993 Jan 11; 315(3):242-6. PubMed ID: 8422913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
    Francischetti IM, Ghazaleh FA, Reis RA, Carlini CR, Guimarães JA.
    Arch Biochem Biophys; 1998 May 15; 353(2):239-50. PubMed ID: 9606958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M, Banno Y, Naganawa T.
    Platelets; 2005 Dec 15; 16(8):482-91. PubMed ID: 16287615
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinase blockers: new platelet activation inhibitors.
    Rendu F, Eldor A, Grelac F, Levy-Toledano S, Levitzki A.
    Blood Coagul Fibrinolysis; 1990 Dec 15; 1(6):713-6. PubMed ID: 2133252
    [Abstract] [Full Text] [Related]

  • 11. ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets.
    Sargeant P, Farndale RW, Sage SO.
    J Biol Chem; 1993 Aug 25; 268(24):18151-6. PubMed ID: 7688740
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine kinases activate store-mediated Ca2+ entry in human platelets through the reorganization of the actin cytoskeleton.
    Rosado JA, Graves D, Sage SO.
    Biochem J; 2000 Oct 15; 351 Pt 2(Pt 2):429-37. PubMed ID: 11023829
    [Abstract] [Full Text] [Related]

  • 13. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein.
    Asahi M, Yanagi S, Ohta S, Inazu T, Sakai K, Takeuchi F, Taniguchi T, Yamamura H.
    FEBS Lett; 1992 Aug 31; 309(1):10-4. PubMed ID: 1511739
    [Abstract] [Full Text] [Related]

  • 14. Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis.
    Coffey MJ, Jarvis GE, Gibbins JM, Coles B, Barrett NE, Wylie OR, O'Donnell VB.
    Circ Res; 2004 Jun 25; 94(12):1598-605. PubMed ID: 15142951
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA, Scheible S, Marx-Grunwitz A, Presek P.
    Thromb Haemost; 1998 Dec 25; 80(6):976-81. PubMed ID: 9869170
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by genistein, a tyrosine kinase inhibitor.
    Tseng CP, Verma AK.
    Mol Pharmacol; 1996 Aug 25; 50(2):249-57. PubMed ID: 8700131
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses.
    Murphy CT, Kellie S, Westwick J.
    Eur J Biochem; 1993 Sep 01; 216(2):639-51. PubMed ID: 7690703
    [Abstract] [Full Text] [Related]

  • 19. Protein tyrosine phosphorylation in equine platelets: the effect of stimulation by thrombin and platelet-activating factor (PAF).
    Dillon AM, Heath MF.
    Equine Vet J; 1995 Nov 01; 27(6):448-58. PubMed ID: 8565942
    [Abstract] [Full Text] [Related]

  • 20. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY, Wu YC, Wu CC.
    Mol Pharmacol; 2006 Oct 01; 70(4):1380-9. PubMed ID: 16837624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.